ConductScience.org, home

Paper26733552

Prostate Cancer, Version 1.2016.

Mohler JL and 31 others. J Natl Compr Canc Netw, 2016. Cited by 528 papers, by iCite.

Cite this record

ConductScience Library. Prostate Cancer, Version 1.2016. Papers, record 26733552. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26733552

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Prostate Cancer, Version 1.2016.
PubMed
Journal
J Natl Compr Canc Netw
PubMed
Year
2016
PubMed
Publication types
Journal Article, Practice Guideline, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
528
iCite
Relative citation ratio, by iCite
20.5
iCite
Revised in PubMed
2022-04-10
PubMed

Authors32

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Mohler JLJames L
2Armstrong AJAndrew J
3Bahnson RRRobert R
4D'Amico AVAnthony Victor
5Davis BJBrian J
6Eastham JAJames A
7Enke CACharles A
8Farrington TAThomas A
9Higano CSCelestia S
10Horwitz EMEric M
11Hurwitz MMichael
12Kane CJChristopher J
13Kawachi MHMark H
14Kuettel MMichael
15Lee RJRichard J
16Meeks JJJoshua J
17Penson DFDavid F
18Plimack ERElizabeth R
19Pow-Sang JMJulio M
20Raben DDavid

Source PubMed

See all 32 authorsDownload CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Prostatic NeoplasmsMajor topic
Disease Progression
Humans
Male
Neoplasm Staging
Orchiectomy
Prognosis

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
P30CA060553NIH

Source NIH RePORTER

Download CSV of grants

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT03031821Metformin in Patients Initiating ADT as Prevention and Intervention of Metabolic SyndromeBackground

Source ClinicalTrials.gov

Download CSV of trials

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in27639611Editorial Comment.https://conductscience.org/library/papers/27639611

Source PubMed

Download CSV of comments and corrections

Cited by293

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 528 citations.

PMIDTitleJournalYearIn PapersSource
42840510SWI/SNF chromatin remodelers in prostate cancer progression.Front Epigenet Epigenom2023https://conductscience.org/library/papers/42840510PubMed
42666623Salvage prostate therapies for local pelvic recurrence after primary radiation for prostate cancer.BJUI Compass2026https://conductscience.org/library/papers/42666623PubMed
42528154Trends in the Adoption of MRI Associated Biopsy for Active Surveillance Within the First Year After Localized Prostate Cancer Diagnosis: A SEER-Medicare Cohort Study.Cancer Med2026https://conductscience.org/library/papers/42528154PubMed
42211501Update of the MSKCC nomogram for metastatic progression and its role in active surveillance: the Italian TPCP cohort.Front Oncol2026https://conductscience.org/library/papers/42211501PubMed
41827775mpMRI-Based Risk Estimation to Optimize Prostate Cancer Patient Selection for Active Surveillance.Cancers (Basel)2026https://conductscience.org/library/papers/41827775PubMed
40759791New frontiers in prostate cancer treatment from systemic therapy to targeted therapy.EMBO Mol Med2025https://conductscience.org/library/papers/40759791PubMed
40698265Adaption of the Memorial Sloan Kettering Cancer Center Nomograms for the Prediction of Prostate Cancer-specific Death in Sweden: A Population-based Cohort Study.Eur Urol Open Sci2025https://conductscience.org/library/papers/40698265PubMed
40614127Identifying cribriform and intraductal histology on magnetic resonance imaging-assisted biopsy for patients with intermediate-grade prostate cancer: Implications for active surveillance.Cancer2025https://conductscience.org/library/papers/40614127PubMed
40586954Impact of the PI-QUAL MRI quality score on histopathological up-staging from MRI fusion biopsy to final prostatectomy specimen.World J Urol2025https://conductscience.org/library/papers/40586954PubMed
40426959Current Status and Future Perspectives of Nuclear Medicine in Prostate Cancer from Imaging to Therapy: A Comprehensive Review.Biomedicines2025https://conductscience.org/library/papers/40426959PubMed
40276087Real‑world data on the outcomes of upfront docetaxel in hormone‑sensitive metastatic prostate cancer.Oncol Lett2025https://conductscience.org/library/papers/40276087PubMed
39859516Exosomal Liquid Biopsy in Prostate Cancer: A Systematic Review of Biomarkers for Diagnosis, Prognosis, and Treatment Response.Int J Mol Sci2025https://conductscience.org/library/papers/39859516PubMed
39816941Comparison of oncological outcomes between extended and no pelvic lymph node dissection in patients with high- or very high-risk prostate cancer: a multi-institutional study.Prostate Int2024https://conductscience.org/library/papers/39816941PubMed
39539558Association between beta-blocker atenolol use and prostate cancer upgrading in active surveillance.BJUI Compass2024https://conductscience.org/library/papers/39539558PubMed
39528898Surgery versus radiation for clinically positive nodal prostate cancer in an other cause mortality risk weighted cohort.Int Urol Nephrol2025https://conductscience.org/library/papers/39528898PubMed
39410925Prognostic value of three clinical nutrition scoring system (NRI, PNI, and CONUT) in elderly patients with prostate cancer.Front Nutr2024https://conductscience.org/library/papers/39410925PubMed
39410867Prostate Cancer: A Review of Genetics, Current Biomarkers and Personalised Treatments.Cancer Rep (Hoboken)2024https://conductscience.org/library/papers/39410867PubMed
39272888Traditional Prostate Cancer Risk Assessment Scales Do Not Predict Outcomes from Brain Metastases: A Population-Based Predictive Nomogram.Cancers (Basel)2024https://conductscience.org/library/papers/39272888PubMed
39176293The association of type and number of high-risk criteria with cancer-specific mortality in prostate cancer patients treated with radical prostatectomy.Curr Urol2024https://conductscience.org/library/papers/39176293PubMed
39143030Survival by first-line therapy and prognostic group among men with metastatic castration-resistant prostate cancer.Cancer Med2024https://conductscience.org/library/papers/39143030PubMed

See all 293 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/26733552

GET https://conductscience.org/api/papers/v1/26733552/authors?page=2